Quality-of-life measures in the evaluation of antihypertensive drug therapy: reliability, validity, and quality-of-life domains
- 1 November 1996
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 18 (6) , 1276-1295
- https://doi.org/10.1016/s0149-2918(96)80082-8
Abstract
No abstract availableThis publication has 60 references indexed in Scilit:
- The Nottingham health profile: Subjective health status and medical consultationsPublished by Elsevier ,2002
- Quality of life: an overview of the concept and measuresInternational Journal of Clinical Pharmacy, 1995
- Treatment of Mild Hypertension with Low Once‐Daily Doses of a Sustained‐Release Capsule Formulation of VerapamilThe Journal of Clinical Pharmacology, 1995
- Quality-of-Life Instruments in HypertensionPharmacoEconomics, 1994
- Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine.Hypertension, 1992
- Documentation of an instrument for assessment of subjective CNS-related symptoms during cardiovascular pharmacotherapyCardiovascular Drugs and Therapy, 1989
- Standards for validating health measures: Definition and contentJournal of Chronic Diseases, 1987
- The Effects of Antihypertensive Therapy on the Quality of LifeNew England Journal of Medicine, 1986
- The CES-D ScaleApplied Psychological Measurement, 1977
- Coefficient alpha and the internal structure of testsPsychometrika, 1951